As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Uveitis Drugs Market: By Product: Small Molecules, Biologics; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; SWOT Analysis; Porter’s Five Forces Analysis; EMR’s Key Indicators for Demand EMR’s Key Indicators for Price; Competitive Landscape; Industry Events and Developments

Global Uveitis Drugs Market Outlook

The global uveitis drugs market is estimated to grow at a CAGR of almost 6.8% in the forecast period of 2021-2026. The global uveitis drugs market is being driven by the increased prevalence of eye disorders, the growing preference for combination therapies, and the development of novel diagnostic tools and solutions to treat patients with uveitis.

 

Global Uveitis Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Uveitis is associated with several inflammatory diseases, which results in the swelling of the eye and destroy eye tissues. The global uveitis drugs market can be divided based on segments like products and regions.

 

Global Uveitis Drugs Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Product:
    • Small Molecules
    • Biologics

The EMR report looks into the regional uveitis drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Uveitis Drugs Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

With the advancement in technology and development in the field of uveitis drugs, the uveitis drugs market is witnessing an increased growth. The growing preference for AI-based medical devices to analyse the level of diabetic retinopathy and improved diagnostic tools and methods to treat patients with uveitis are expected to aid the uveitis drugs market growth in the future. Further, the growing investments in R&D by major players and the deployment of advanced technology are expected to provide a further boost to the uveitis drugs market growth.

The small molecules segment, among other product types, is expected to lead the global uveitis drugs industry over the forecast period owing to the growing utilisation of corticosteroids to treat uveitis. Region-wise, the Asia Pacific is expected to witness the highest growth rate over the forecast period owing to the growing prevalence of uveitis and the increased efforts by various governments and private organisations, creating awareness regarding the disease and its treatment, which will provide the industry with significant growth opportunities.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global uveitis drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AbbVie Inc. (NYSE: ABBV)
  • Allergan Plc 
  • Johnson & Johnson Services Inc. 
  • Novartis AG 
  • Pfizer Inc. 
  • Others

The EMR report gives an in-depth insight into the uveitis drugs market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region
Breakup by Product Small Molecules, Biologics
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered AbbVie Inc. (NYSE: ABBV), Allergan Plc (NYSE: AGN), Johnson & Johnson Services Inc. (NYSE: JNJ), Novartis AG (SWX: NOVN), Pfizer Inc. (NYSE: PFE), Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraints
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Global Uveitis Drugs Market Analysis
    6.1    Figure: Global Uveitis Drugs Historical Market (2016-2020) & Forecast (2021-2026)
    6.2    Chart: Global Uveitis Drugs Market Breakup by Product 
        6.2.1    Small Molecules
        6.2.2    Biologics
    6.3    Figure: Global Uveitis Drugs Market Breakup by Product: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    Small Molecules
        6.3.2    Biologics
    6.4    Chart: Global Uveitis Drugs Market Breakup by Region
        6.4.1    North America
            6.4.1.1    United States of America
            6.4.1.2    Canada
        6.4.2    Europe
            6.4.2.1    Germany
            6.4.2.2    United Kingdom
            6.4.2.3    France
            6.4.2.4    Italy
            6.4.2.5    Others
        6.4.3    Asia Pacific
            6.4.3.1    China
            6.4.3.2    Japan
            6.4.3.3    India
            6.4.3.4    ASEAN
            6.4.3.5    Others
        6.4.4    Latin America
            6.4.4.1    Brazil
            6.4.4.2    Mexico
            6.4.4.3    Argentina
            6.4.4.4    Others
        6.4.5    Middle East & Africa
            6.4.5.1    Saudi Arabia
            6.4.5.2    United Arab Emirates
            6.4.5.3    Nigeria
            6.4.5.4    South Africa
            6.4.5.5    Others
    6.5    Figure: Global Uveitis Drugs Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    North America
            6.5.1.1    United States of America
            6.5.1.2    Canada
        6.5.2    Europe
            6.5.2.1    Germany
            6.5.2.2    United Kingdom
            6.5.2.3    France
            6.5.2.4    Italy
            6.5.2.5    Others
        6.5.3    Asia Pacific
            6.5.3.1    China
            6.5.3.2    Japan
            6.5.3.3    India
            6.5.3.4    ASEAN
            6.5.3.5    Others
        6.5.4    Latin America
            6.5.4.1    Brazil
            6.5.4.2    Mexico
            6.5.4.3    Argentina
            6.5.4.4    Others
        6.5.5    Middle East & Africa
            6.5.5.1    Saudi Arabia
            6.5.5.2    United Arab Emirates
            6.5.5.3    Nigeria
            6.5.5.4    South Africa
            6.5.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    EMR’s Key Indicators for Demand
10    EMR’s Key Indicators for Price
11    Competitive Landscape & Supplier Analysis

    11.1    AbbVie Inc. (NYSE: ABBV)
        11.1.1    Company Overview
        11.1.2    Financial Analysis
    11.2    Allergan Plc (NYSE: AGN)
        11.2.1    Company Overview
        11.2.2    Financial Analysis
    11.3    Johnson & Johnson Services Inc. (NYSE: JNJ)
        11.3.1    Company Overview
        11.3.2    Financial Analysis
    11.4    Novartis AG (SWX: NOVN)
        11.4.1    Company Overview
        11.4.2    Financial Analysis
    11.5    Pfizer Inc. (NYSE: PFE)
        11.5.1    Company Overview
        11.5.2    Financial Analysis
    11.6    Others
12    Industry Events and Developments 

Key Questions Answered in the Report

The global uveitis drugs market is projected to grow at a CAGR of 6.8% between 2021 and 2026.

The major drivers of the industry, such as the increasing prevalence of eye disorders, the growing preference for combination therapies, and the development of novel diagnostic tools and solutions to treat patients with uveitis, are expected to aid the market growth.

The key market trend guiding the industry growth includes the rising awareness regarding the disease and its treatment.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major products in the industry are small molecules and biologics.

The major players in the industry are AbbVie Inc., Allergan Plc, Johnson & Johnson Services Inc., Novartis AG, and Pfizer Inc., among others.

Analyst Review

The global uveitis drugs market is being driven by the rising prevalence of eye disorders. Aided by the technological advancements, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 6.8%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the industry can be segmented into small molecules and biologics. The major regional markets for the product are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AbbVie Inc., Allergan Plc, Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc., and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER